Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

5.7K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K
GTPases and their Regulation02:14

GTPases and their Regulation

10.3K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
10.3K
GTPases and their Regulation02:14

GTPases and their Regulation

3.3K
3.3K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

12.5K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
12.5K
Rab Cascades01:25

Rab Cascades

3.8K
Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
3.8K
Rab Proteins01:14

Rab Proteins

5.4K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secondary Production of Gaseous Nitrated Phenols in Polluted Urban Environments.

Environmental science & technology·2021
Same author

miR-133a silencing rescues glucocorticoid-induced bone loss by regulating the MAPK/ERK signaling pathway.

Stem cell research & therapy·2021
Same author

In vivo self-assembled small RNAs as a new generation of RNAi therapeutics.

Cell research·2021
Same author

Evaluation of the CARDS toxin and its fragment for the serodiagnosis of Mycoplasma pneumoniae infections.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2021
Same author

Time-resolved HO<sub>2</sub> detection with Faraday rotation spectroscopy in a photolysis reactor.

Optics express·2021
Same author

Gray Matter Density of the Dorsomedial Prefrontal Cortex Mediates the Relationship Between Catastrophizing and Anxiety in Somatic Symptom Disorder.

Neuropsychiatric disease and treatment·2021
Same journal

The role of RAC1 in resistance to targeted therapies in cancer.

Small GTPases·2025
Same journal

The structure of KRAS<sup>G12C</sup> bound to divarasib highlights features of potent switch-II pocket engagement.

Small GTPases·2025
Same journal

Small GTPase Rac promotes hyphal formation and microconidiogenesis in <i>Trichophyton rubrum</i>.

Small GTPases·2025
Same journal

To stay in shape and keep moving: MLL emerges as a new transcriptional regulator of Rho GTPases.

Small GTPases·2023
Same journal

Serine phosphorylation of the RhoGEF Trio stabilizes endothelial cell-cell junctions.

Small GTPases·2023
Same journal

Rab6-mediated retrograde trafficking from the Golgi: the trouble with tubules.

Small GTPases·2023
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

10.4K

Drugging the Ral GTPase.

Chao Yan1, David N M Jones, Dan Theodorescu

  • 1a Departments of Surgery (Urology) and Pharmacology ; University of Colorado ; Aurora , CO USA.

Small Gtpases
|August 18, 2015
PubMed
Summary
This summary is machine-generated.

Small molecule inhibitors targeting RAL GTPases show promise in fighting lung cancer. These novel compounds, which block tumor growth and metastasis, offer new therapeutic strategies for cancer treatment.

Keywords:
GTPaseRalRasallostericmetastasispersonalized medicineprecision medicinesmall moleculetargeted therapy

More Related Videos

Comparing the Affinity of GTPase-binding Proteins using Competition Assays
10:37

Comparing the Affinity of GTPase-binding Proteins using Competition Assays

Published on: October 8, 2015

9.7K
Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

11.3K

Related Experiment Videos

Last Updated: Apr 5, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

10.4K
Comparing the Affinity of GTPase-binding Proteins using Competition Assays
10:37

Comparing the Affinity of GTPase-binding Proteins using Competition Assays

Published on: October 8, 2015

9.7K
Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

11.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • RAL GTPases are key regulators of cell growth and are implicated in various cancers.
  • Dysregulation of RAL GTPases contributes to tumor progression and metastasis.

Purpose of the Study:

  • To develop and characterize novel small molecule inhibitors of RAL GTPases.
  • To evaluate the antitumor activity of these inhibitors in human lung cancer models.

Main Methods:

  • Development of allosteric, non-competitive inhibitors targeting GDP-bound RAL.
  • In vitro testing of inhibitor efficacy against human lung cancer cell lines.

Main Results:

  • Successfully developed the first small molecule inhibitors of RAL with demonstrated antitumor activity.
  • Inhibitors bind to an allosteric site on GDP-bound RAL, blocking its function.

Conclusions:

  • RAL GTPase inhibitors represent a promising new therapeutic avenue for lung cancer.
  • These inhibitors may be effective in combination therapies targeting the RAS signaling pathway.
  • The findings provide a basis for targeting other GTPases.